Table 2 Demographics and pathology results in low-risk histologic stage IA EC after matching
Variable | Low-risk histology | Low-risk histology with MI | ||||
|---|---|---|---|---|---|---|
MIS (n = 132) | OP(n = 132) | P value | MIS (n = 101) | OP(n = 101) | P value | |
Age ≥ 60yrs | 38(28.79%) | 38(28.79%) | >0.99 | 38(37.62%) | 38(37.62%) | >0.99 |
BMI>24(kg/m2) | 20(15.15%) | 20(15.15%) | >0.99 | 21(20.79%) | 21(20.79%) | >0.99 |
Arterial hypertension | 45(34.09%) | 39(29.55%) | 0.428 | 32(31.68%) | 32(31.68%) | >0.99 |
Diabetes mellitus | 13(9.85%) | 19(14.39%) | 0.258 | 15(14.85%) | 15(14.85%) | >0.99 |
Menopause | 66(50.00%) | 80(60.61%) | 0.083 | 69(68.32%) | 66(65.35%) | 0.654 |
Nulliparity | 14(10.61%) | 6(4.55%) | 0.063 | 4(3.96%) | 8(7.92%) | 0.234 |
Lymphadenectomy | 75(56.82%) | 76(57.58%) | 0.901 | 63(62.38%) | 55(54.46%) | 0.253 |
Radiotherapy | 3(2.27%) | 3(2.27%) | >0.99 | 4(3.96%) | 4(3.96%) | >0.99 |
Chemotherapy | 15(11.36%) | 15(11.36%) | >0.99 | 13(12.87%) | 13(12.87%) | >0.99 |
MI | 89(67.42%) | 89(67.42%) | >0.99 | – | – | – |
Grade | Â | Â | >0.99 | Â | Â | >0.99 |
 G1 | 60(45.45%) | 56(42.42%) |  | 27(26.73%) | 25(24.75%) |  |
 G2 | 72(54.55%) | 76(57.58%) |  | 74(73.27%) | 76(75.25%) |  |
Positive LVSI | 3(2.27%) | 3(2.27%) | >0.99 | 7(6.93%) | 4(3.96%) | 0.352 |
Positive peritoneal cytology | 15(11.36%) | 9(6.82%) | 0.199 | 6(5.94%) | 13(12.87%) | 0.147 |
Recurrence | 3(2.27%) | 0(0.00%) | 0.246 | 0(0.00%) | 3(2.97%) | 0.246 |
Death | 2(1.52%) | 0(0.00%) | 0.498 | 0(0.00%) | 0(0.00%) | – |
Length of follow-up (months) | 52.08 ± 26.25 | 82.91 ± 33.58 | <0.001 | 84.68 ± 33.17 | 53.94 ± 25.06 | <0.001 |